Vibrio cholerae O1 with ctxB7 variant genotype acquired qnrVC mediated ciprofloxacin resistance in Yavatmal, India P. Kumar Clinical Microbiology and.

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

P.-Y. Lévy Clinical Microbiology and Infection

Helicobacter pylori resistance to antibiotics in 2014 in France detected by phenotypic and genotypic methods A. Ducournau, L. Bénéjat, E. Sifré, E. Bessède,

The greatest steps towards the discovery of Vibrio cholerae

C.N. van Ettekoven, D. van de Beek, M.C. Brouwer

Gut bacterial microbiota and obesity

I.J. Schalk Clinical Microbiology and Infection

O.J. Dyar, G. Tebano, C. Pulcini Clinical Microbiology and Infection

Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients

D. Khalil, M. Hultin, M.U. Rashid, B. Lund

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources N. Singh,

Migrant health—a cause for concern?

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Virological tools to diagnose and monitor hepatitis C virus infection

Refugee crisis and re-emergence of forgotten infections in Europe

Quinolone resistance among Shigella spp

Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries J.A. Otter, N.T. Mutters, E. Tacconelli, A.

A.E. Muller, U. Theuretzbacher, J.W. Mouton

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013 L.E.B. Nabarro, R.A. Lever, M. Armstrong,

Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice? T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt

Results from a mathematical model for human monocytic ehrlichiosis

Vector control: a cornerstone in the malaria elimination campaign

Update and new insights in encephalitis

Training for the infectious diseases speciality in Norway

Isospora belli Clinical Microbiology and Infection

Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman Clinical.

Levofloxacin in the treatment of ventilator-associated pneumonia

R. Bitterman, M. Paul, D. Polak, Y. Geffen

Metagenomics and probiotics

M. Aires-de-Sousa Clinical Microbiology and Infection

Previously unknown species of Aspergillus

T.M. File Clinical Microbiology and Infection

Sexually acquired Zika virus: a systematic review

Systematic review of antibiotic consumption in acute care hospitals

Abstracts cont. Clinical Microbiology and Infection

Testing patients with non-specific symptoms for antibodies against Borrelia burgdorferi sensu lato does not provide useful clinical information about.

Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection E. Knops, E. Heger Clinical Microbiology.

Vaccinations against respiratory tract infections at Hajj

C. Tamalet, P. Colson, E. Decroly, C. Dhiver, I. Ravaux, A. Stein, D

Antimicrobial drug development – the past, the present, and the future

H. Leblebicioglu, C. Eroglu Clinical Microbiology and Infection

C. Gagliotti, L. Nobilio, M.L. Moro

S. M. Bartsch, J. A. McKinnell, L. E. Mueller, L. G. Miller, S. K

Dynamics of hepatitis B virus quasispecies heterogeneity in association with nucleos(t)ide analogue treatment determined by MALDI-TOF MS M. Rybicka,

Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013 U. Fedeli, E. Schievano,

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

M.T. Pérez-Rodríguez, A. Sousa, P. Martínez-Cueto, A. Ocampo

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

A. van Samkar, M. C. Brouwer, Y. Pannekoek, A. van der Ende, D

Survival of rhinoviruses on human fingers

The atypical pneumonias: clinical diagnosis and importance

Abstracts Clinical Microbiology and Infection

Virology: a scientific discipline facing new challenges

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

R. Khatib, G. Simeunovic, M. Sharma, M. G. Fakih, L. B. Johnson, L

A. Manzur, F. Gudiol Clinical Microbiology and Infection

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Great oaks from little acorns grow—21 years of CMI

Impact of antibiotic restrictions: the patient's perspective

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

Rajko Saletinger, Mario Poljak, Franc Strle

The future of diagnostic bacteriology

Presentation transcript:

Vibrio cholerae O1 with ctxB7 variant genotype acquired qnrVC mediated ciprofloxacin resistance in Yavatmal, India P. Kumar Clinical Microbiology and Infection Volume 23, Issue 12, Pages 1005-1006 (December 2017) DOI: 10.1016/j.cmi.2017.06.019 Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Molecular dynamics simulation of QnrVC complex with gyrase. Snapshots (a–j) taken at 5-nanosecond intervals up to 50 nanoseconds. Clinical Microbiology and Infection 2017 23, 1005-1006DOI: (10.1016/j.cmi.2017.06.019) Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions